901 related articles for article (PubMed ID: 30686075)
1. Mesoporous silica nanoparticles: synthesis, classification, drug loading, pharmacokinetics, biocompatibility, and application in drug delivery.
Li Z; Zhang Y; Feng N
Expert Opin Drug Deliv; 2019 Mar; 16(3):219-237. PubMed ID: 30686075
[TBL] [Abstract][Full Text] [Related]
2. Mesoporous silica nanoparticles for therapeutic/diagnostic applications.
Jafari S; Derakhshankhah H; Alaei L; Fattahi A; Varnamkhasti BS; Saboury AA
Biomed Pharmacother; 2019 Jan; 109():1100-1111. PubMed ID: 30551360
[TBL] [Abstract][Full Text] [Related]
3. Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery.
Tang F; Li L; Chen D
Adv Mater; 2012 Mar; 24(12):1504-34. PubMed ID: 22378538
[TBL] [Abstract][Full Text] [Related]
4. Novel scheme for rapid synthesis of hollow mesoporous silica nanoparticles (HMSNs) and their application as an efficient delivery carrier for oral bioavailability improvement of poorly water-soluble BCS type II drugs.
Li T; Geng T; Md A; Banerjee P; Wang B
Colloids Surf B Biointerfaces; 2019 Apr; 176():185-193. PubMed ID: 30616109
[TBL] [Abstract][Full Text] [Related]
5. Polydopamine-based surface modification of mesoporous silica nanoparticles as pH-sensitive drug delivery vehicles for cancer therapy.
Chang D; Gao Y; Wang L; Liu G; Chen Y; Wang T; Tao W; Mei L; Huang L; Zeng X
J Colloid Interface Sci; 2016 Feb; 463():279-87. PubMed ID: 26550786
[TBL] [Abstract][Full Text] [Related]
6. Mesoporous silica nanoparticles for intracellular controlled drug delivery.
Vivero-Escoto JL; Slowing II; Trewyn BG; Lin VS
Small; 2010 Sep; 6(18):1952-67. PubMed ID: 20690133
[TBL] [Abstract][Full Text] [Related]
7. Mesoporous silica nanoparticles: facile surface functionalization and versatile biomedical applications in oncology.
Huang R; Shen YW; Guan YY; Jiang YX; Wu Y; Rahman K; Zhang LJ; Liu HJ; Luan X
Acta Biomater; 2020 Oct; 116():1-15. PubMed ID: 32911102
[TBL] [Abstract][Full Text] [Related]
8. In vivo bio-safety evaluations and diagnostic/therapeutic applications of chemically designed mesoporous silica nanoparticles.
Chen Y; Chen H; Shi J
Adv Mater; 2013 Jun; 25(23):3144-76. PubMed ID: 23681931
[TBL] [Abstract][Full Text] [Related]
9. Tailored Mesoporous Silica Nanoparticles for Controlled Drug Delivery: Platform Fabrication, Targeted Delivery, and Computational Design and Analysis.
She X; Chen L; Yi Z; Li C; He C; Feng C; Wang T; Shigdar S; Duan W; Kong L
Mini Rev Med Chem; 2018; 18(11):976-989. PubMed ID: 27145854
[TBL] [Abstract][Full Text] [Related]
10. Successfully tailoring the pore size of mesoporous silica nanoparticles: exploitation of delivery systems for poorly water-soluble drugs.
Jia L; Shen J; Li Z; Zhang D; Zhang Q; Duan C; Liu G; Zheng D; Liu Y; Tian X
Int J Pharm; 2012 Dec; 439(1-2):81-91. PubMed ID: 23078857
[TBL] [Abstract][Full Text] [Related]
11. Preparation and Controllability of Mesoporous Silica Nanoparticles.
Yamamoto E; Kuroda K
Enzymes; 2018; 44():1-10. PubMed ID: 30360809
[TBL] [Abstract][Full Text] [Related]
12. Chitosan-capped mesoporous silica nanoparticles as pH-responsive nanocarriers for controlled drug release.
Hu X; Wang Y; Peng B
Chem Asian J; 2014 Jan; 9(1):319-27. PubMed ID: 24115568
[TBL] [Abstract][Full Text] [Related]
13. A Review on Recent Technologies and Patents on Silica Nanoparticles for Cancer Treatment and Diagnosis.
Gupta A; Kushwaha SS; Mishra A
Recent Pat Drug Deliv Formul; 2020; 14(2):126-144. PubMed ID: 32928094
[TBL] [Abstract][Full Text] [Related]
14. Egg-yolk core-shell mesoporous silica nanoparticles for high doxorubicin loading and delivery to prostate cancer cells.
Tiburcius S; Krishnan K; Jose L; Patel V; Ghosh A; Sathish CI; Weidenhofer J; Yang JH; Verrills NM; Karakoti A; Vinu A
Nanoscale; 2022 May; 14(18):6830-6845. PubMed ID: 35441642
[TBL] [Abstract][Full Text] [Related]
15. Facile Synthesis of Three Types of Mesoporous Silica Microspheres as Drug Delivery Carriers and their Sustained-Release Properties.
Zhu Y; Wang B; Chen J; He J; Qiu X
Curr Drug Deliv; 2023; 20(9):1337-1350. PubMed ID: 35713141
[TBL] [Abstract][Full Text] [Related]
16. Mesoporous silica nanoparticles carrying multiple antibiotics provide enhanced synergistic effect and improved biocompatibility.
Gounani Z; Asadollahi MA; Pedersen JN; Lyngsø J; Skov Pedersen J; Arpanaei A; Meyer RL
Colloids Surf B Biointerfaces; 2019 Mar; 175():498-508. PubMed ID: 30572158
[TBL] [Abstract][Full Text] [Related]
17. Functionalized mesoporous silica particles for application in drug delivery system.
Pang J; Luan Y; Yang X; Jiang Y; Zhao L; Zong Y; Li Z
Mini Rev Med Chem; 2012 Jul; 12(8):775-88. PubMed ID: 22512562
[TBL] [Abstract][Full Text] [Related]
18. A systemic review on development of mesoporous nanoparticles as a vehicle for transdermal drug delivery.
Kolimi P; Narala S; Youssef AAA; Nyavanandi D; Dudhipala N
Nanotheranostics; 2023; 7(1):70-89. PubMed ID: 36593800
[TBL] [Abstract][Full Text] [Related]
19. An anti-ROS/hepatic fibrosis drug delivery system based on salvianolic acid B loaded mesoporous silica nanoparticles.
He Q; Zhang J; Chen F; Guo L; Zhu Z; Shi J
Biomaterials; 2010 Oct; 31(30):7785-96. PubMed ID: 20674009
[TBL] [Abstract][Full Text] [Related]
20. Multifunctional Mesoporous Silica Nanoparticles for Cancer Therapy and Imaging.
Dilnawaz F
Curr Med Chem; 2019; 26(31):5745-5763. PubMed ID: 29714137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]